OpenAI and Moderna announced the pair have expanded their partnership to offer the pharma giant's employees access to ChatGPT Enterprise, a platform that allows customizable GPTs to be developed for a specific purpose.
Through ChatGPT Enterprise, users can create GPTs by beginning a conversation with ChatGPT, then providing extra knowledge on a subject or giving it instructions. Users can also...
